Identification of the HLA-A24 peptide epitope within cytomegalovirus protein pp65 recognized by CMV-specific cytotoxic T lymphocytes

被引:53
作者
Masuoka, M
Yoshimuta, T
Hamada, M
Okamoto, M
Fumimori, T
Honda, J
Oizumi, K
Itoh, K
机构
[1] Kurume Univ, Sch Med, Dept Internal Med 1, Kurume, Fukuoka 8300011, Japan
[2] Kurume Univ, Sch Med, Dept Immunol, Kurume, Fukuoka 8300011, Japan
关键词
D O I
10.1089/08828240152716619
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Among cytomegalovirus (CMV) tegument proteins, phosphoprotein 65 (pp65) has been identified as the important target antigen of the cytotoxic T lymphocyte (CTL) response against the virus. We synthesized seven CMV-pp65-derived peptides carrying an HLA-A24-binding motif, and investigated the ability of these peptides to induce CMV-specific CTL. We identified one nonamer peptide (pp65(113-121); VYALPLKML) able to bind HLA-A24 and induce CTL responses in vitro in peripheral blood mononuclear cells (PBMC) from CMV-seropositive individuals. The peptide-specific CTLs generated were capable of recognizing pp65 expressed on CMV-infected fibroblasts as well as pp65(113-121) peptide bound to the surface of C1R-A*2402 cells in an HLA-A24-restricted manner. The pp65113-121 peptide thus might be considered a synthetic peptide vaccine in HLA-A24-positive individuals.
引用
收藏
页码:369 / 377
页数:9
相关论文
共 22 条
[1]   Recognition of human cytomegalovirus gene products by HCMV-specific cytotoxic T cells [J].
Boppana, SB ;
Britt, WJ .
VIROLOGY, 1996, 222 (01) :293-296
[2]   HUMAN CYTOMEGALOVIRUS-SPECIFIC CYTO-TOXIC T-CELLS - RELATIVE FREQUENCY OF STAGE-SPECIFIC CTL RECOGNIZING THE 72-KD IMMEDIATE EARLY PROTEIN AND GLYCOPROTEIN-B EXPRESSED BY RECOMBINANT VACCINIA VIRUSES [J].
BORYSIEWICZ, LK ;
HICKLING, JK ;
GRAHAM, S ;
SINCLAIR, J ;
CRANAGE, MP ;
SMITH, GL ;
SISSONS, JGP .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 168 (03) :919-931
[3]   Development of a candidate HLA A*0201 restricted peptide-based vaccine against human cytomegalovirus infection [J].
Diamond, DJ ;
York, J ;
Sun, JY ;
Wright, CL ;
Forman, SJ .
BLOOD, 1997, 90 (05) :1751-1767
[4]   Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8+ T lymphocytes in healthy seropositive donors [J].
Gillespie, GMA ;
Wills, MR ;
Appay, V ;
O'Callaghan, C ;
Murphy, M ;
Smith, N ;
Sissons, P ;
Rowland-Jones, S ;
Bell, JI ;
Moss, PAH .
JOURNAL OF VIROLOGY, 2000, 74 (17) :8140-8150
[5]   Cytotoxic T lymphocyte (CTL) responses to human cytomegalovirus pp65, IE1-exon4, gB, pp150, and pp28 in healthy individuals:: Reevaluation of prevalence of IE1-specific CTLs [J].
Gyulai, Z ;
Endresz, V ;
Burian, K ;
Pincus, S ;
Toldy, J ;
Cox, WI ;
Meric, C ;
Plotkin, S ;
Gönczöl, E ;
Berencsi, K .
JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (05) :1537-1546
[6]   Role of strong anchor residues in the effective binding of 10-mer and 11-mer peptides to HLA-A*2402 molecules [J].
Ibe, M ;
Moore, YI ;
Miwa, K ;
Kaneko, Y ;
Yokota, S ;
Takiguchi, M .
IMMUNOGENETICS, 1996, 44 (04) :233-241
[7]  
Ikeda-Moore Y, 1997, J IMMUNOL, V159, P6242
[8]  
Imanishi T., 1992, HLA 1991, P1065
[9]  
Kikuchi M, 1999, INT J CANCER, V81, P459, DOI 10.1002/(SICI)1097-0215(19990505)81:3<459::AID-IJC21>3.0.CO
[10]  
2-6